There is a possibility that the production of certain autoantibodies, especially cancer-associated autoantibodies, is triggered by the formation of cryptic epitopes resulting from a mutation of the target antigens, e.g., mutation in a gene encoding TIF-1 protein triggers production of anti-TIF1 antibodies. Here, TRIM24 is linked to cancer.